Stay updated on Long-term Exenatide Use Clinical Trial
Sign up to get notified when there's something new on the Long-term Exenatide Use Clinical Trial page.

Latest updates to the Long-term Exenatide Use Clinical Trial page
- Check6 days agoChange DetectedThe page now presents the completed AstraZeneca observational study of long-term exenatide use in Japanese patients with type 2 diabetes, including participation criteria, study locations, and safety and other outcome measures.SummaryDifference47%

- Check13 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA sitewide NIH announcement about terminology changes appears above the 403 error page. The site revision label also changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check41 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1. The study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error and minimal layout, replacing the previous study record content. Previously visible sections such as the study description, enrollment, locations, and related details are no longer accessible on this page.SummaryDifference15%

- Check62 days agoChange DetectedThe footer now displays Revision: v3.7.0, replacing Revision: v3.6.6. This indicates a software version update in the site's underlying system rather than new content.SummaryDifference0.0%

Stay in the know with updates to Long-term Exenatide Use Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Exenatide Use Clinical Trial page.